M. O'Neill

A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE)

H. Hurwitz, J. Bendell, G. Blobe, 2011, Cancer Chemotherapy and Pharmacology.

A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)

H. Hurwitz, D. Niedzwiecki, G. Blobe, 2019, Cancer Chemotherapy and Pharmacology.

A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer.

H. Hurwitz, R. Riedel, H. Pang, 2018, The oncologist.

A case report of microsatellite instability (MSI)-high, HER2 amplified pancreatic adenocarcinoma with central nervous system metastasis.

C. Anders, J. Abbruzzese, M. Morse, 2021, AME case reports.